# Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg

> **NCT07562282** · NA · RECRUITING · sponsor: **Ain Shams University** · enrollment: 140 (estimated)

## Conditions studied

- Kidney Stone
- Ureteric Stone

## Interventions

- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT07562282
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-07-10
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07562282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07562282, "Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07562282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*